Answers are grounded in this paper and cite their sources.
The most prevalent genotypes of NAT2 gene in Moroccans are those which encode slow acetylation phenotype (72.39%), leading to a high risk of ATDH. Most Moroccans are homozygous for c1 allele of CYP2E1 gene which aggravates hepatotoxicity in slow acetylators. This genetic background should be taken into account in determining the minimum dose of INH needed to treat Moroccan TB patients, in order to decrease adverse effects.
No takes yet. Share an insight, caveat, or question.
Guaoua et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: